KUROFILL Trademark

Trademark Overview


On Thursday, May 8, 2008, a trademark application was filed for KUROFILL with the United States Patent and Trademark Office. The USPTO has given the KUROFILL trademark a serial number of 79062215. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, May 8, 2018. This trademark is owned by Kuros Biosurgery AG. The KUROFILL trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Cosmetic products, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cement, which contain hormones and/or growth factors to support restoration and reconstruction in reconstructive or cosmetic surgery; materials for permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous soft tissue, in particular fatty tissue and muscle tissue, other than for medical purposes, namely, protein and/or peptide and/or polyalkylenoxide preparations; carrier materials of synthetic and/or natural origin for cosmetic purposes, namely, matrices, solutions, gels, pastes, microparticles, nanoparticles, beads and cements, in particular consisting of fibrin and/or polyethylene glycol for retention or increased release of peptides or proteins, in particular hormones and growth factors, i.e., substances which stimulate growth of an organism or maintain growth for use in reconstructive, regenerative, generative and ...

Artificial tissue replacement for restoring, maintaining and/or improving the function of diseased or damaged human or animal tissue (tissue engineering); synthetic implants, and transplants and modified implants and transplants, tissue, cells and/or molecules for replacing and/or for supporting the function of missing or damaged body parts; synthetic hard and soft tissue, in particular synthetic bone for transplantation purposes and diagnostic purposes, synthetic bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement; modified implants and transplants with engineered endogenous material, tissue, cells or molecules for replacing and/or for supporting the function of missing or damaged body parts
kurofill

General Information


Serial Number79062215
Word MarkKUROFILL
Filing DateThursday, May 8, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, May 8, 2018
Registration Number3818446
Registration DateTuesday, July 13, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2010

Trademark Statements


Goods and ServicesCosmetic products, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cement, which contain hormones and/or growth factors to support restoration and reconstruction in reconstructive or cosmetic surgery; materials for permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous soft tissue, in particular fatty tissue and muscle tissue, other than for medical purposes, namely, protein and/or peptide and/or polyalkylenoxide preparations; carrier materials of synthetic and/or natural origin for cosmetic purposes, namely, matrices, solutions, gels, pastes, microparticles, nanoparticles, beads and cements, in particular consisting of fibrin and/or polyethylene glycol for retention or increased release of peptides or proteins, in particular hormones and growth factors, i.e., substances which stimulate growth of an organism or maintain growth for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; pharmaceutical products and preparations, namely, protein and/or peptide preparations, in particular for locally supporting the formation or regeneration of missing or damaged body parts, in particular of hard or soft tissue, in particular skin or bone; pharmaceutical or medical formulations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements of synthetic and/or natural origin for medical purposes, namely, for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue, in particular comprising fibrin and/or polyoxyalkyleneoxides, namely, polyethylene glycol for retention or sustained release of peptides, proteins and/or allograft materials, in particular hormones, growth factors and/or demineralized bone matrix, i.e., substances which stimulate growth of an organism or maintain growth; healthcare preparations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; biomedical products and biotechnology products for medical purposes, namely, peptides and proteins like hormones and growth factors or allograft materials used to spur regrowth and formation and to repair tissue, namely, tissue of bone, skin, organs, tendons, ligament, cartilage; materials for medical purposes for permanent or temporary enlargement, filling, repair, stabilization, support and/or regeneration of hard or soft tissue, in particular bone, intervertebral disk, cartilage, fatty tissue and muscle tissue, namely, protein and/or peptide and/or polyalkylenoxide preparations; biocompatible permanent or temporary adhesives and sealants, in particular for human and animal organs, soft and hard tissue for medical purposes; biocompatible separating materials, namely, anti-adhesion materials for avoiding undesired adhesion of organs and/or soft parts for medical purposes; implants and transplants of human derived autologous or allograft materials; autologous and allograft soft tissue for cosmetic and medical purposes; autologous and allograft hard and soft tissue in particular bone for transplantation purposes, bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement
Goods and ServicesArtificial tissue replacement for restoring, maintaining and/or improving the function of diseased or damaged human or animal tissue (tissue engineering); synthetic implants, and transplants and modified implants and transplants, tissue, cells and/or molecules for replacing and/or for supporting the function of missing or damaged body parts; synthetic hard and soft tissue, in particular synthetic bone for transplantation purposes and diagnostic purposes, synthetic bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement; modified implants and transplants with engineered endogenous material, tissue, cells or molecules for replacing and/or for supporting the function of missing or damaged body parts
Pseudo MarkKUROS FILL

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 17, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 17, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKuros Biosurgery AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameKuros Biosurgery AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameKuros Biosurgery AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Friday, December 7, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, December 7, 2018DEATH OF INTERNATIONAL REGISTRATION
Thursday, January 25, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, November 17, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Monday, October 23, 2017TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, October 23, 2017INVALIDATION PROCESSED
Tuesday, October 17, 2017TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 17, 2017CANCELLED SECTION 71
Saturday, May 18, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, October 27, 2010FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, October 27, 2010FINAL DISPOSITION PROCESSED
Wednesday, October 13, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 13, 2010REGISTERED-PRINCIPAL REGISTER
Friday, June 4, 2010NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, May 20, 2010NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, May 20, 2010NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, April 27, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2010PUBLISHED FOR OPPOSITION
Tuesday, March 23, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 23, 2010ASSIGNED TO LIE
Friday, March 5, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 5, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 12, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 12, 2010TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, February 12, 2010EX PARTE APPEAL-INSTITUTED
Friday, February 12, 2010JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, February 12, 2010EXPARTE APPEAL RECEIVED AT TTAB
Friday, November 27, 2009ASSIGNED TO EXAMINER
Tuesday, August 25, 2009NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, August 25, 2009FINAL REFUSAL E-MAILED
Tuesday, August 25, 2009FINAL REFUSAL WRITTEN
Monday, July 6, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 6, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 6, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 6, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 6, 2009REFUSAL PROCESSED BY IB
Tuesday, January 6, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 6, 2009REFUSAL PROCESSED BY MPU
Sunday, January 4, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, January 3, 2009NON-FINAL ACTION WRITTEN
Tuesday, December 23, 2008APPLICATION FILING RECEIPT MAILED
Friday, December 19, 2008ASSIGNED TO EXAMINER
Friday, December 19, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, December 18, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB